๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma

โœ Scribed by Timothy Feyma; Gregory T. Carter; Michael D. Weiss


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
223 KB
Volume
38
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Myotonic dystrophy type 1 (DM1) is an autosomalโ€dominant multisystemic disorder that may rarely be associated with benign and malignant neoplasms. Cases of both thymoma and myasthenia gravis in association with DM1 are extremely rare. A literature review revealed only three prior reports. We present a 51โ€yearโ€old man with a family history of DM1 and fluctuating diplopia and ptosis, who was found to have acetylcholine receptorโ€“binding antibodies, thymoma, and a clinical presentation compatible with ocular myasthenia gravis as well as positive genetic testing for DM1. Needle electromyographic (EMG) study demonstrated diffuse runs of myotonic discharges in multiple muscles, consistent with the diagnosis of DM1. Singleโ€fiber EMG showed both increased jitter and blocking. Due to somatic instability, which has been shown previously in DM1, the myotonin protein kinase (DMPK) gene appears to act as a tumor suppressor. Therefore, abnormal CTG repeat expansions in the gene could lead to the development of thymoma and myasthenia gravis. Muscle Nerve 38: 916โ€“920, 2008


๐Ÿ“œ SIMILAR VOLUMES


Association of spinal and bulbar muscula
โœ Kenji Jinnai; Keisuke Nishimoto; Kyoko Itoh; Kozo Hashimoto; Keiichi Takahashi ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 176 KB

## Abstract A man with spinal and bulbar muscular atrophy (SBMA) had a short (CTG)n expansion in the myotonic dystrophy protein kinase gene as well as (CAG)n expansion in the androgen receptor gene in leukocytes. The patient had the characteristic clinical findings of SBMA, but none of myotonic dys

Creatine monohydrate supplementation doe
โœ Mark Tarnopolsky; Douglas Mahoney; Terry Thompson; Heather Naylor; Timothy J. Do ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB

## Abstract Creatine monohydrate (CrM) supplementation may increase strength in some types of muscular dystrophy. A recent study in myotonic muscular dystrophy type 1 (DM1) did not find a significant treatment effect, but measurements of muscle phosphocreatine (PCr) were not performed. We completed